This summary was created by AI, based on 1 opinions in the last 12 months.
Nebius Group, trading under the symbol NBIS-Q, has seen a significant rise, with shares up 108% since October 21 and 7.9% today. Originating from Yandex, often dubbed the 'Google of Russia', the company is focused on acquiring GPUs and building new data centers, positioning itself primarily in the AI infrastructure sector. However, the financial details remain sparse, with a troubling adjusted EBITDA of -$7 million noted last December. While Citron Research had previously recommended the stock during its jump last December, it's important to consider Citron's troubled history with fraud allegations in pump-and-dump schemes. Nebius Group claims proximity to NVIDIA, but that assertion is met with skepticism. Additionally, the stock currently trades at a high 20 times its projected full-year revenue, raising concerns about its valuation in the market.
Nebius Group is a American stock, trading under the symbol NBIS-Q on the NASDAQ (NBIS). It is usually referred to as NASDAQ:NBIS or NBIS-Q
In the last year, 1 stock analyst published opinions about NBIS-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Nebius Group .
Nebius Group was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Nebius Group .
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Nebius Group published on Stockchase.
On 2025-02-19, Nebius Group (NBIS-Q) stock closed at a price of $47.26.
Up 108% since Oct. 21. A cloud server. Up 7.9% today. It used to be Yandex, the Google of Russia, which no one paid attention to. They plan to acquire as many GPUs as they can and build-new data centres. Their core is the AI infrastructure business. There's limited financial info, but adjusted EBITDA is -$7 million billion last December. When shares jumped last December, Citron Research recommended it twice, but Citron has been charged with fraud twice in an alleged pump and dump operation. NBIS claims to be close to NVDA, but that is in doubt. It trades at 20x its full-year revenue forecast--very expensive.